Clinical Trial: Lenvatinib Efficacy in Metastatic Neuroendocrine Tumors (TALENT) October 1, 2020 Read More »
Neuroendocrine Tumor Drug Clinical Trial – Cabozantinib (includes news on Pheochromoctyoma and Paraganglioma) November 27, 2020 Read More »